bq-123
Showing 1 - 8 of 8
Cardiovascular Diseases, Cardiovascular Risk Factor, Vasoconstriction Trial in Arlington (BQ-788, BQ-123, L-Arginine)
Recruiting
- Cardiovascular Diseases
- +2 more
- BQ-788
- +5 more
-
Arlington, TexasScience and Engineering Research and Innovation Building
Feb 7, 2022
Heart Failure Trial in Salt Lake City (BQ-123)
Completed
- Heart Failure
- BQ-123
-
Salt Lake City, UtahVA Salt Lake City Health Care System, Salt Lake City, UT
Dec 17, 2021
COPD, Pulmonary Artery Hypertension, Heart Failure Trial in Salt Lake City (Maximum Exercise Tests, BH4, L-NMMA, Vitamin C,
Recruiting
- Chronic Obstructive Pulmonary Disease
- +3 more
- Maximum Exercise Tests
- +6 more
-
Salt Lake City, UtahGeorge E Wahlen VA Medical Center
Sep 15, 2021
Pulmonary Hypertension Trial in Boston (BQ-123)
Completed
- Pulmonary Hypertension
- BQ-123
-
Boston, MassachusettsBrigham and Women's Hospital
Nov 1, 2018
Myocardial Reperfusion Injury Trial in Rochester (BQ-123, Placebo)
Completed
- Myocardial Reperfusion Injury
- BQ-123
- Placebo
-
Rochester, MinnesotaMayo Clinic
Jul 3, 2014
ST-Elevation Myocardial Infarction Trial in Vienna (Placebo, BQ-123)
Completed
- ST-Elevation Myocardial Infarction
- Placebo
- BQ-123
-
Vienna, Vienna-Austria, AustriaMedical University of Vienna
Apr 27, 2013
Coronary Artery Disease, Aorto-coronary Bypass Grafting Trial in Vienna (BQ-123, NaCl)
Unknown status
- Coronary Artery Disease
- Aorto-coronary Bypass Grafting
- BQ-123
- NaCl
-
Vienna, AustriaMedical University of Vienna
Aug 2, 2012
Healthy Trial in Vienna (drug, device, other)
Completed
- Healthy
- BQ-123
- +4 more
-
Vienna, AustriaDepartment of Clinical Pharmacology, Medical University of Vienn
Aug 9, 2012